2023
DOI: 10.1002/advs.202205783
|View full text |Cite
|
Sign up to set email alerts
|

The NO Answer for Autism Spectrum Disorder

Abstract: Autism spectrum disorders (ASDs) include a wide range of neurodevelopmental disorders. Several reports showed that mutations in different high-risk ASD genes lead to ASD. However, the underlying molecular mechanisms have not been deciphered. Recently, they reported a dramatic increase in nitric oxide (NO) levels in ASD mouse models. Here, they conducted a multidisciplinary study to investigate the role of NO in ASD. High levels of nitrosative stress biomarkers are found in both the Shank3 and Cntnap2 ASD mouse… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 118 publications
0
5
0
Order By: Relevance
“…iPSC-based models offer an alternative to understanding the effect of genomic mutations and associations on neural cells 6,16,21,[43][44][45][46][47][48] . The majority of studies investigated NPCs and neurons derived from ASD patient-specific iPSC in vitro and only a few havestudied the role of glial cells from ASD patients using iPSC technology.…”
Section: Discussionmentioning
confidence: 99%
“…iPSC-based models offer an alternative to understanding the effect of genomic mutations and associations on neural cells 6,16,21,[43][44][45][46][47][48] . The majority of studies investigated NPCs and neurons derived from ASD patient-specific iPSC in vitro and only a few havestudied the role of glial cells from ASD patients using iPSC technology.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, interesting studies have put in light connections between the specific genetic mutation of the Shank3 gene occurring in autism, a condition associated with deficits in communication and social skills, and excessive NO synthesis, which is responsible for aberrant protein nitrosation and S-nitrosylation [ 64 , 65 , 66 , 67 ]. Elevated levels of different SNO proteins functionally involved in the synaptic vesicle cycle, neurotransmission, and glutamatergic pathway, such as protein phosphatase catalytic subunit α-Ppp3ca, syntaxin-1a, vesicle-associated membrane protein 3, and others, were found in Shank3 KO mouse models [ 66 , 67 ]. Collectively, these observations provide insights into the specific pathological role of dysregulated NO production in autism spectrum disorders.…”
Section: The Overstimulation Of Nnos In Cns Disease Developmentmentioning
confidence: 99%
“…Moreover, this compound is able to slow down the progressive neurodegeneration in a Parkinson’s disease in vivo model [ 87 ]. Very recently, 7-NI was also used to demonstrate the pathological role of NO in autism development, and the in vivo administration of this compound to a Shank3 mouse (M1) model of autism disease led to the recovery of a normal behavioral phenotype [ 67 ].…”
Section: Inhibitors Of Nnos As Modulators Of Cns Disease Developmentmentioning
confidence: 99%
“…In the brain, endogenous NO acts as a diffusible neurotransmitter mainly produced by nNOS, activated upon glutamate binding to postsynaptic N-methyl-Daspartate (NMDA) receptors (Chachlaki and Prevot, 2020;Fernando et al, 2022). Since Nnos has been identified at different time points in various cell types of the central nervous system (CNS) (Maccallini and Amoroso, 2023), in certain areas of the brain, it is only temporarily expressed (Chung et al, 2004;Imura et al, 2005) and there is a gradual increase in others (Tripathi et al, 2023) during embryonic and postnatal development. Additionally, during the first month of postnatal life, histochemical and immunocytochemical research have characterized the distribution of NO-producing neurons in the rat corpus callosum structure (cc) (Barbaresi et al, 2020).…”
Section: Introductionmentioning
confidence: 99%